Yu-Tzu Tai

28PUBLICATIONS
83CO-AUTHORS
Molecular targetsGene and molecular therapyPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Feb 13, 2023
BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma.

Keiji Kurata, Mehmet K Samur, Priscilla Liow

|Jan 11, 2023
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma.

Keiji Kurata, Anna James-Bott, Mark A Tye

|Jun 15, 2022
Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes.

Mark Bustoros, Shankara Anand, Romanos Sklavenitis-Pistofidis

Pageof 5